Current Regulatory Topics in Europe

Dr. Ilona Reischl
Austrian Medicines and Medical Devices Agency, AGES/MEA

Ilona Reischl joined the Austrian Medicines and Medical Devices Agency AGES/MEA in March 2006 and currently holds the position of a Senior Assessor in the Institute for Assessment and Analysis. Her current focus is the quality assessment of biological medicinal products including Advanced Therapy Medicinal products. She is the Austrian member of the European Medicines Agency Biologics Working Party and the Committee for Advanced Therapies. Her regulatory expertise includes Clinical Trials and Non-interventional trials, scientific advice procedures and compassionate use, a reflection of a strong interest in the development of biological medicinal products.
Starting in academic research in immunology she transitioned to the regulation of medicines at the US Food and Drug Administration (FDA) assessing the quality of biological investigational new drug applications and conducting research on T cell signalling.
Her initial training comprises a degree in pharmacy, a PhD in immunology/allergology and postdoctoral experience at an industrial research institute, the University of Southampton (UK) and the National Institutes of Health (USA).